Home
>
National Drug Code (NDC)
>
Hiprex
Hiprex - 0068-0277-61 - (methenamine hippurate)
Drug Information of Hiprex
| Product NDC: | 0068-0277 |
| Proprietary Name: | Hiprex |
| Non Proprietary Name: | methenamine hippurate |
| Active Ingredient(s): | 1 g/1 & nbsp; methenamine hippurate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hiprex
| Product NDC: | 0068-0277 |
| Labeler Name: | Sanofi-Aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017681 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19760909 |
Package Information of Hiprex
| Package NDC: | 0068-0277-61 |
| Package Description: | 100 TABLET in 1 BOTTLE (0068-0277-61) |
NDC Information of Hiprex
| NDC Code | 0068-0277-61 |
| Proprietary Name | Hiprex |
| Package Description | 100 TABLET in 1 BOTTLE (0068-0277-61) |
| Product NDC | 0068-0277 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methenamine hippurate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19760909 |
| Marketing Category Name | NDA |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Substance Name | METHENAMINE HIPPURATE |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes |
